Our Lady's Children's Hospital, Crumlin Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2011
NCT03698630
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Our Lady's Children's Hospital, Crumlin

Active Ingredients

Drugs in Phase 4 Trials (4)

dexamethasone (1 trial)

fentanyl (Innovar) (1 trial)

morphine (1 trial)

prednisolone (hydeltra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Sickle Cell (Phase 4)

Asthma (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4